Evaluasi Penggunaan Berbagai Macam Polimer untuk Matriks Penghantaran Obat Secara Transdermal

Riska Kurnia Oktaviani; Anita Sukmawati

Authors

Riska Kurnia Oktaviani Universitas Muhammadiyah Pekajangan Pekalongan
Anita Sukmawati

Keywords:

Matrix patch transdermal, Polymers, Ethyl cellulose, PVP, HPMC, Copolymers of acrylate

Abstract

The transdermal patch matrix delivery system can be modified by various of additives so that the drug delivery profile can be controlled. Polymer is a part important in the drug delivery system in transdermal determine and control the rate of release of drug from the reservoir of the drug in the patch transdermal, enables the delivery of drug that is safe, constant, and effectively to the body. This study aims to determine the effect of using various polymers for transdermal drug delivery matrix based on several literatures that have been published in the last 5 years. Research is a literature review. Sources of data using a database of scientific to get the sources relevant to that associated with the use of polymers in the formulation of the matrix patch transdermal. The samples were the articles of research that is associated with the use of polymers in the formulation of the matrix patch transdermal, which published 5 years past and can be accessed free full text. The use of polymers in the formulation of the matrix transdermal patch could affect the physicochemical characteristic of the matrix transdermal patch. Use of ethyl cellulose preferably in combination with polymer hydrophilic such as PVP and HPMC, because the patch become drier and brittle, however the use of PVP and HPMC in the huge amount may affects preparations more moist, thicker and heavier so it will increase patient’s convenience of. The combination of hydrophobic and hydrophilic polymers affected the drug release process from transdermal patch preparation. The addition of polymer hydrophilic was a factor essential to increase the overall solubility. Increasing high concentrations of PVP or HPMC combined with ethylcellulose and concentration eudragit®RL 100 combined with eudragit®RS 100 would increase the release profiles of the drug.

References

Akhlaq, M., Arshad, M. S., Mudassir, A. M., Hussain, A., Kucuk, I., Haj-Ahmad, R., Rasekh, M., & Ahmad, Z. (2016). Formulation and evaluation of anti-rheumatic dexibuprofen transdermal patches: a quality-by-design approach. Journal of Drug Targeting, 24(7), 603–612. https://doi.org/10.3109/1061186X.2015.1116538

Akram, M. R., & Ahmad, M. (2018). Formulation design and development of matrix diffusion controlled transdermal drug delivery of glimepiride. 349–364.

Alexander, A., Dwivedi, S., Giri, T. K., Saraf, S., Saraf, S., dan Tripathi, D. K. (2012).Approaches for breaking the barriers of drug permeation through transdermal drug delivery.Journal of Controlled Release, 164, 26-40.

Alkilani, A. Z., Mccrudden, M. T. C., & Donnelly, R. F. (2015). Transdermal Drug Delivery: Innovative Pharmaceutical Developments Based on Disruption of the Barrier Properties of the stratum corneum. 438–470. https://doi.org/10.3390/pharmaceutics7040438

Bharkatiya, M., Nema, R. K., dan Bhatnagar, M. (2010).Designing and Characterization of Drug Free Patches for Transdermal Application.International Journal of Pharmaceutical Sciences and Drug Research.2 (1), 35-39

Bartosova, L., dan Bajgar, J. (2012). Transdermal Drug Delivery In Vitro Using Diffusion Cells. Czech Republic: Current Medicinal Chemistry 19, 4671- 4677

Doungdaw, C., Preeda, T., Amaraporn, W., Veerawat, T., & Buraphacheep, J. V. (2017). Fabrication and Evaluation of Eudragit® Polymeric Films for Transdermal Delivery of Piroxicam. Pharmaceutical Development and Technology, 0(0), 000. https://doi.org/10.1080/10837450.2017.1319864

Ganti, S. S., Bhattaccharjee, S. A., Murnane, K. S., Blough, B. E., & Banga, A. K. (2018). Formulation and evaluation of 4-benzylpiperidine drug-in-adhesive matrix type transdermal patch. International Journal of Pharmaceutics, 550(1–2), 71–78. https://doi.org/10.1016/j.ijpharm.2018.08.033

Gujjar, M., & Banga, A. K. (2014). Iontophoretic and microneedle mediated transdermal delivery of glycopyrrolate. Pharmaceutics, 6(4), 663–671. https://doi.org/10.3390/pharmaceutics6040663

Hanbali, O. A. A. L. (2019). Transdermal patches : Design and current approaches to painless drug delivery. 69, 197–215.

Hashmat, D., Harris, M., Id, S., Ali, F. R., & Siddiqui, F. (2020). Lornoxicam controlled release transdermal gel patch : Design , characterization and optimization using co-solvents as penetration enhancers. 1–23. https://doi.org/10.1371/journal.pone.0228908

Jafri, I., Shoaib, M. H., Yousuf, R. I., & Ali, F. R. (2019). Effect of permeation enhancers on in vitro release and transdermal delivery of lamotrigine from Eudragit®RS100 polymer matrix-type drug in adhesive patches. Progress in Biomaterials, 8(2), 91–100. https://doi.org/10.1007/s40204-019-0114-9

Jan, S. U., Gul, R., & Jalaludin, S. (2020). Original Article FORMULATION AND EVALUATION OF TRANSDERMAL PATCHES OF PSEUDOEPHEDRINE HCL. 12(3).

Jung, E., Lee, E. Y., Choi, H. K., Ban, S. J., Choi, S. H., Kim, J. S., Yoon, I. S., & Kim, D. D. (2015). Development of drug-in-adhesive patch formulations for transdermal delivery of fluoxetine: In vitro and in vivo evaluations. International Journal of Pharmaceutics, 487(1–2), 49–55. https://doi.org/10.1016/j.ijpharm.2015.04.012

Larrañeta, E., Lutton, R. E. M., Woolfson, A. D., & Donnelly, R. F. (2016). Microneedle arrays as transdermal and intradermal drug delivery systems: Materials science, manufacture and commercial development. Materials Science and Engineering R: Reports, 104, 1–32. https://doi.org/10.1016/j.mser.2016.03.001

Lopez-Castellano, A., dan Merino, V. (2010).Chemical Enhancers.Current Technologies to Increase the Transdermal Delivery of Drugs, 23

Ramadhani, U. K. S., Djajadisastra, J., & Iskandarsyah, I. (2017). Pengaruh Polimer dan Peningkat Penetrasi Terhadap Karakter Penetrasi Matriks Sediaan Patch Transdermal Karvedilol. Jurnal Ilmu Kefarmasian Indonesia, 15(2), 120. https://doi.org/10.35814/jifi.v15i2.501

Rowe, R. ., Sheske, P. ., & Quinn, M. . (2009). Handbook of Pharmaceutical Exipient. In Handbook of Pharmaceutical Exipient (VI, hal. 257, 273, 413). Pharmaceutical Press and American Pharmacists Assosiation.

Shahid, N., Siddique, M. I., Razzaq, Z., Katas, H., Waqas, M. K., & Rahman, K. U. (2018). Fabrication and characterization of matrix type transdermal patches loaded with tizanidine hydrochloride: potential sustained release delivery system. Drug Development and Industrial Pharmacy, 44(12), 2061–2070. https://doi.org/10.1080/03639045.2018.1509081

Togatorop, B., Sinaga, K. R., Suwarso, E., & Iksen, I. (2018). EFFECT OF DIFFERENT POLYMER AND OLEIC ACID ENCHANCER IN NIFEDIPINE MATRIX TRANSDERMAL PATCH FORMULATION AND EVALUATION. 11(2), 516–521.

Watkinson, A.C. (2012). Transdermal and topical drug delivery today.Transdermal and Topical Drug Delivery: Principles and Practice. Halaman.357-366.

Wolff, H. (2000). Optimal process design for the manufacture of transdermal drug delivery systems. 3(5).